CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers
NCT ID: NCT06237816
Last Updated: 2025-11-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
35 participants
INTERVENTIONAL
2025-05-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient Education Intervention
A multimedia educational series is designed to provide patient education on cancer clinical trials.
The following topics are addressed:
* What is a clinical trial?
* Types of clinical trials.
* Phases of clinical trials.
* Benefits and drawbacks.
* Costs.
* FAQs. This section covers common myths and clarifies these myths using a Q\&A format.
* How to join a clinical trial. Information about eligibility and informed consent.
* Clinical trial stories. Testimonies from oncology providers and patients. Each module is approximately 2-5 minutes, and they can be reviewed in the order/schedule preferred by the patient.
The overall program is 30 minutes to view including the videos. The tablet provided to patients provides additional benefits for participation.
Patient Education Intervention
Multimedia Educational Videos
Provider Education Intervention
The provider education intervention will consist of 3 provider informational sessions conducted individually. These individual provider sessions will be conducted by teleconference by the research team and scheduled according to provider's availability.
Provider workshops are designed to provide both a background on clinical trial infrastructure in Hawaii and resources for additional information. The content of these sessions includes:
* An overview of clinical trials infrastructure in Hawaii.
* Available trials in Hawaii. At each informational session, the research team will review available trials and any new/upcoming trials with the provider.
* An overview of how to get involved in clinical trials. As experience and background re: clinical trials may vary across providers, the content of these informational sessions will be tailored to each provider. Following the initial session, 2 additional meetings will be scheduled in 4-6 months as follow-up sessions.
Provider Education Intervention
Provider workshops via zoom
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient Education Intervention
Multimedia Educational Videos
Provider Education Intervention
Provider workshops via zoom
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have received treatment, are receiving cancer treatment at the time of enrollment, or estimated to start treatment within 90 days.
* Patients must be ≥ 18 years of age. Patients must be able to read, write, and speak English. Study materials and telephone calls are only available in English.
Patients must be residents of Hawaii, Kauai, or Maui counties.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Agency for Healthcare Research and Quality (AHRQ)
FED
University of Hawaii
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Izumi Okado, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Hawaii Cancer Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Univesity of Hawaii Cancer Center
Honolulu, Hawaii, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Aaron Roberts
Role: primary
Tomomi Otaki
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Okado-2023-2
Identifier Type: -
Identifier Source: org_study_id